AKRO
Price
$30.97
Change
-$1.41 (-4.35%)
Updated
Nov 13 closing price
119 days until earnings call
IOVA
Price
$8.95
Change
-$0.06 (-0.67%)
Updated
Nov 14, 10:55 AM (EDT)
104 days until earnings call
Ad is loading...

AKRO vs IOVA

Header iconAKRO vs IOVA Comparison
Open Charts AKRO vs IOVABanner chart's image
Akero Therapeutics
Price$30.97
Change-$1.41 (-4.35%)
Volume$543.77K
CapitalizationN/A
Iovance Biotherapeutics
Price$8.95
Change-$0.06 (-0.67%)
Volume$9.12K
CapitalizationN/A
AKRO vs IOVA Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AKRO vs. IOVA commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Buy and IOVA is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (AKRO: $30.97 vs. IOVA: $9.00)
Brand notoriety: AKRO and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 102% vs. IOVA: 158%
Market capitalization -- AKRO: $2.16B vs. IOVA: $2.74B
AKRO [@Biotechnology] is valued at $2.16B. IOVA’s [@Biotechnology] market capitalization is $2.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileIOVA’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • IOVA’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than IOVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 3 TA indicator(s) are bullish while IOVA’s TA Score has 5 bullish TA indicator(s).

  • AKRO’s TA Score: 3 bullish, 5 bearish.
  • IOVA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than AKRO.

Price Growth

AKRO (@Biotechnology) experienced а -12.22% price change this week, while IOVA (@Biotechnology) price change was -25.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

AKRO is expected to report earnings on Mar 13, 2025.

IOVA is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($2.74B) has a higher market cap than AKRO($2.16B). AKRO YTD gains are higher at: 32.634 vs. IOVA (10.701). AKRO has higher annual earnings (EBITDA): -200.16M vs. IOVA (-418.89M). AKRO has more cash in the bank: 760M vs. IOVA (413M). AKRO has less debt than IOVA: AKRO (36.3M) vs IOVA (81.7M). IOVA has higher revenues than AKRO: IOVA (32.8M) vs AKRO (0).
AKROIOVAAKRO / IOVA
Capitalization2.16B2.74B79%
EBITDA-200.16M-418.89M48%
Gain YTD32.63410.701305%
P/E RatioN/AN/A-
Revenue032.8M-
Total Cash760M413M184%
Total Debt36.3M81.7M44%
FUNDAMENTALS RATINGS
IOVA: Fundamental Ratings
IOVA
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKROIOVA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHLOX9.320.03
+0.32%
Philotimo Focused Growth and Income
PMIEX25.06N/A
N/A
Federated Hermes International Equity A
FMMMX46.25-0.06
-0.13%
American Funds AMCAP 529-F-2
FDESX41.34-0.06
-0.14%
Fidelity Advisor Diversified Stock O
IVVIX20.67-0.03
-0.14%
Delaware Ivy Smid Cap Core Fund Class I

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
-4.35%
ETNB - AKRO
64%
Loosely correlated
-1.49%
VTYX - AKRO
51%
Loosely correlated
-3.81%
BEAM - AKRO
48%
Loosely correlated
-1.57%
DNLI - AKRO
45%
Loosely correlated
-0.84%
PLRX - AKRO
45%
Loosely correlated
-0.36%
More